Vitamin D deficiency and posterior subcapsular cataract

Craig J Brown,1 Faical Akaichi21The Eye Center, Fayetteville, AR, USA; 2Scotland’s Rural College, Edinburgh, UKPurpose: To evaluate risk factors associated with posterior subcapsular cataract (PSC) development and the relationship between vitamin D deficiency and etiology of PSC.Methods: O...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Brown CJ, Akaichi F
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://doaj.org/article/aff7110fcb0a4a9ead0856644cae4481
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:aff7110fcb0a4a9ead0856644cae4481
record_format dspace
spelling oai:doaj.org-article:aff7110fcb0a4a9ead0856644cae44812021-12-02T01:47:50ZVitamin D deficiency and posterior subcapsular cataract1177-5483https://doaj.org/article/aff7110fcb0a4a9ead0856644cae44812015-06-01T00:00:00Zhttp://www.dovepress.com/vitamin-d-deficiency-and-posterior-subcapsular-cataract-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Craig J Brown,1 Faical Akaichi21The Eye Center, Fayetteville, AR, USA; 2Scotland’s Rural College, Edinburgh, UKPurpose: To evaluate risk factors associated with posterior subcapsular cataract (PSC) development and the relationship between vitamin D deficiency and etiology of PSC.Methods: Of 195 consecutive patients from a private ophthalmology practice, diagnosed with PSC, serum vitamin D3 (25-OH D) levels were obtained for 175, and associations among risk factors, comorbidities, and PSC were assessed.Results: In all 175 PSC patients, mean 25-OH D levels were low (24 ng/mL ±11 SD) compared with age/sex-matched standards. Significant differences in 25-OH D levels were noted between PSC subjects taking/not taking calcium supplements, systemic steroids, osteoporosis medications, etc. Alone, smoking status and calcium channel blockers and/or topical steroids use made no significant difference in PSC subjects 25-OH D levels, but two or more of these factors were associated with lowered levels of 25-OH D (P<0.001). Low vitamin D was correlated with female sex, autoimmune disease, and non-skin cancer diagnosis, but not with age, or other comorbidities or medication use. In five early-stage PSC patients taking 5,000 IU of 25-OH D daily for vitamin D deficiency, there was resolution of their cataracts during the 2-year follow-up period.Conclusion: Vitamin D levels for most PSC patients fell below the 30 ng/mL calcium homeostasis threshold. Some comorbidities and non-ophthalmic interventions are associated with the development of PSC at less depressed levels of 25-OH D. In this series, vitamin D deficiency was associated with PSC cataract, suggesting that raising the level of vitamin D intake may reduce PSC incidence.Keywords: posterior subcapsular, cataracts, vitamin D deficiency, risk factors, hypocalcemia, case reportBrown CJAkaichi FDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2015, Iss default, Pp 1093-1098 (2015)
institution DOAJ
collection DOAJ
language EN
topic Ophthalmology
RE1-994
spellingShingle Ophthalmology
RE1-994
Brown CJ
Akaichi F
Vitamin D deficiency and posterior subcapsular cataract
description Craig J Brown,1 Faical Akaichi21The Eye Center, Fayetteville, AR, USA; 2Scotland’s Rural College, Edinburgh, UKPurpose: To evaluate risk factors associated with posterior subcapsular cataract (PSC) development and the relationship between vitamin D deficiency and etiology of PSC.Methods: Of 195 consecutive patients from a private ophthalmology practice, diagnosed with PSC, serum vitamin D3 (25-OH D) levels were obtained for 175, and associations among risk factors, comorbidities, and PSC were assessed.Results: In all 175 PSC patients, mean 25-OH D levels were low (24 ng/mL ±11 SD) compared with age/sex-matched standards. Significant differences in 25-OH D levels were noted between PSC subjects taking/not taking calcium supplements, systemic steroids, osteoporosis medications, etc. Alone, smoking status and calcium channel blockers and/or topical steroids use made no significant difference in PSC subjects 25-OH D levels, but two or more of these factors were associated with lowered levels of 25-OH D (P<0.001). Low vitamin D was correlated with female sex, autoimmune disease, and non-skin cancer diagnosis, but not with age, or other comorbidities or medication use. In five early-stage PSC patients taking 5,000 IU of 25-OH D daily for vitamin D deficiency, there was resolution of their cataracts during the 2-year follow-up period.Conclusion: Vitamin D levels for most PSC patients fell below the 30 ng/mL calcium homeostasis threshold. Some comorbidities and non-ophthalmic interventions are associated with the development of PSC at less depressed levels of 25-OH D. In this series, vitamin D deficiency was associated with PSC cataract, suggesting that raising the level of vitamin D intake may reduce PSC incidence.Keywords: posterior subcapsular, cataracts, vitamin D deficiency, risk factors, hypocalcemia, case report
format article
author Brown CJ
Akaichi F
author_facet Brown CJ
Akaichi F
author_sort Brown CJ
title Vitamin D deficiency and posterior subcapsular cataract
title_short Vitamin D deficiency and posterior subcapsular cataract
title_full Vitamin D deficiency and posterior subcapsular cataract
title_fullStr Vitamin D deficiency and posterior subcapsular cataract
title_full_unstemmed Vitamin D deficiency and posterior subcapsular cataract
title_sort vitamin d deficiency and posterior subcapsular cataract
publisher Dove Medical Press
publishDate 2015
url https://doaj.org/article/aff7110fcb0a4a9ead0856644cae4481
work_keys_str_mv AT browncj vitaminddeficiencyandposteriorsubcapsularcataract
AT akaichif vitaminddeficiencyandposteriorsubcapsularcataract
_version_ 1718402917473452032